IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Krensavage Asset Management, LLC

Q1 2022 Holdings

Filed 2022-05-17 | 13 holdings | $23.7M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Biogen Inc(BIIB)COM09062X103$23.5M111,35398.9%
Regeneron Pharmaceuticals(REGN)COM75886F107$46.7K66,8800.2%
Enanta Pharmaceuticals Inc(ENTA)COM29251M106$39.1K548,8280.2%
Mckesson Corp(MCK)COM58155Q103$38.0K124,1650.2%
Alkermes PLC(ALKS)COMG01767105$37.5K1,424,2040.2%
United Therapeutics Corp(UTHR)COM91307C102$36.2K201,6120.2%
Exelixis Inc(EXEL)COM30161Q104$34.7K1,530,4060.1%
Taro Pharmaceutical IndusCOMM8737E108$24.5K565,9510.1%
Eagle Pharmaceuticals Inc(EGRX)COM269796108$5.7K114,7870.0%
Kodiak Sciences Inc(KOD)COM50015M109$3.5K450,6000.0%
Cardinal Health Inc(CAH)COM14149Y108$74813,2000.0%
Nextcure IncCOM65343E108$14930,5910.0%
Assembly Biosciences IncCOM045396108$2110,1000.0%